Dediabetes Logo
Preguntas
Respuestas publicadas conectadas con evidencia
Referencia clínica
Dossieres detallados de intervenciones y resultados
Investigacion reciente
Estudios mas recientes
Acerca de
Cómo funciona deDiabetes
Configuracion
Entrar / Unirse

Liraglutide for Diabetes: Evidence and Outcomes

Ver informe de evidencia

Evidence on outcomes studied for Liraglutide

Evidence related to liraglutide and liraglutide-containing intervention regimens in diabetes studies.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

25
Studies
89
Evidence Pairs
Moderate Evidence
Evidence Strength: 60/100
Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Liraglutide evidence appears to center on HbA1c.

Among 25 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. Body weight has been studied often, while HbA1c appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies
Evidence basis: 7 evidence pairs - 12 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsModerate evidence
HbA1c
7 studies
EvidenceScore™
84/100
ConsistencyScore™
83/100
Body weight
8 studies
EvidenceScore™
83/100
ConsistencyScore™
85/100

Evidence Snapshot

25
Studies
3
Interventions
86
Outcomes
4
Strong evidence signals
2
Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Moderate positive signal

HbA1c

Across 7 studies, Liraglutide shows a consistent moderate positive signal for HbA1c.

7 studies
EvidenceScore™: 84/100
View supporting studies
Moderate positive signal

Body weight

Across 7 studies, Liraglutide shows a consistent moderate positive signal for Body weight.

7 studies
EvidenceScore™: 83.15384615384616/100
View supporting studies
Strong positive signal

Systolic blood pressure

Across 3 studies, Liraglutide shows a consistent strong positive signal for Systolic blood pressure.

3 studies
EvidenceScore™: 79/100
View supporting studies
Moderate positive signal

BMI

Across 3 studies, Liraglutide shows a consistent moderate positive signal for BMI.

3 studies
EvidenceScore™: 75.92307692307692/100
View supporting studies
Neutral signal

Adverse events incidence

Across 2 studies, Liraglutide shows a neutral signal for Adverse events incidence.

2 studies
EvidenceScore™: 69/100
View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Body weight is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Body weight
HbA1c
Body weight
8 studies
EvidenceScore™
83/100
ConsistencyScore™
85/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present
Evidence basis: 7 evidence pairs - 13 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Systolic blood pressure may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Systolic blood pressure
BMI
Systolic blood pressure
3 studies
EvidenceScore™
79/100
ConsistencyScore™
100/100

Why this appears here

Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength
Evidence basis: 6 evidence pairs - 10 studies
View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

What outcomes has Liraglutide been studied for?

HbA1c, Body weight, and Systolic blood pressure are among the most studied areas in relation to Liraglutide.

Emerging Evidence · Consistency cannot yet be determined from the available evidence. · 25 studies · 25 RCTs

View top evidence signals ↓
  1. HbA1c · Strong · 7 studies
  2. Body weight · Strong · 8 studies
  3. Systolic blood pressure · Strong · 3 studies

Does Liraglutide lower HbA1c?

Liraglutide may lower HbA1c.

Strong Evidence · Results are consistent across studies. · 7 studies · 7 RCTs

View top evidence signals ↓
  1. HbA1c · Strong · 7 studies

Does Liraglutide affect body weight?

Liraglutide may affect body weight.

Strong Evidence · Results are consistent across studies. · 8 studies · 8 RCTs

View top evidence signals ↓
  1. Body weight · Strong · 8 studies

Which outcomes have the strongest evidence for Liraglutide?

HbA1c, Body weight, and Systolic blood pressure have the strongest available evidence signals for Liraglutide.

Strong Evidence · Results are consistent across studies. · 12 studies · 12 RCTs

View top evidence signals ↓
  1. HbA1c · Strong · 7 studies
  2. Body weight · Strong · 8 studies
  3. Systolic blood pressure · Strong · 3 studies

Where does Liraglutide need more research?

Waist circumference, incidence of adverse events, and incidence of gastrointestinal disorders need more research in relation to Liraglutide.

Moderate Evidence · Results are mixed and should be interpreted cautiously. · 9 studies · 9 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. Waist circumference · Moderate · 2 studies
  2. Glucose iAUC (OGTT) · Moderate · 2 studies
  3. Adverse events incidence · Moderate · 2 studies
Browse all questions about Liraglutide

Overall Evidence Signals

Among 25 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. Body weight has been studied often, while HbA1c appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Evidence Relationships

Explore the intervention-outcome relationships with the strongest supporting evidence for Liraglutide.

4 strong relationships, ranked by available evidence

Select any relationship to review its supporting studies.

Studies evaluating Liraglutide

Studies connected to this intervention in the evidence record.

Click outcomes and interventions to filter Evidence Explorer when links are available.

Evidence Tracker

Track Liraglutide for Diabetes: Evidence and Outcomes evidence

Save this evidence topic and revisit it as new studies are added.